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Measurement of serum AST activity using
the Seralyzer system
J. F. Stevens
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and R, G. Newall
Miles Laboratories Ltd, Stoke Court, Stoke Poges, Buckinghamshire SL2 4LY,
UK
The performance of the Seralyzer reflectance photometer
system for the measurement ofvarious analytes [2 and
3] and for the enzymes CK and LDH [4] has been
previously reported by the authors. This paper describes
an evaluation of a new assay for AST (Aspartate
Transaminase) determination.
The Seralyzer AST system (Ames Division) is based on
the measurement of the rate of formation of a quinone-
imine dye at 530 nm at a temperature of 37 C, with an
incubation and test period of4 min. Serum specimens are
diluted in 3 prior to analysis; for AST activities above
250 IU/L a further nine-fold dilution is required. The
reaction sequence is shown below:
and high control sera (pooled normal control sera, and
Dade II control serum, respectively) were used for
precision measurements, while 183 routine hospital
clinical serum specimens were analysed in duplicate by
both methods. Total bilirubin estimations were also
made.
The between-run and within-run precision figures were
obtained from the control sera included in each batch of
analyses, and from the patient sera analysed in duplicate,
respectively (table 1). The within-run precision showed
no difference between the Seralyzer and the Centrifichem
(SD 1.66 and 1.78 IU/1 respectively). The between-run
precision showed a better performance for the Centrifi-
chem than the Seralyzer (SD 2"5 as opposed to 6.4) and
this probably reflects the smaller batches used with the
Seralyzer requiring a calibration for each batch--for the
purpose of this study only. In practice, the Seralyzer
calibration would not be redone unless the batch of strips
were changed or the control values were out ofrange. The
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Comparisons were made with the Centrifichem (Baker)
ultra-violet method using Boehringer reagents supplied
for this system (BCL), also performed at 37 C. Normal
Table 2. Linear regression comparison ofaccuracy ofSeralyzer and
Centrifichem AST results, using clinical serum specimens.
Table 1. Analytical precision ofSeralyzer and Centrifichem AST
methodswusing control sera, and duplicate testing ofpatient sera.
Correlation
AST range N Intercept Slope coefficient
0-250 170 7"83 0"95 0"95
Between-run Within-run 0-700 183 7"97 0"95 0"93
Patient sera
Low control High control duplicates
Seralyzer:
Mean (IU/L) 36"4 130"7 86"9
S.D. 5"2 7"6 1.66
Centrifichem:
Mean (IU/L) 23"3 98"3 81’5
S.D. 2"5 2"5 1"78
N 23 23 183
precision was acceptable for clinical purposes. When
comparing the two systems for accuracy (table 2), the
Seralyzer and the Centrifichem showed a good correla-
tion over the range 0-250 IU/1 (r 0"95, slope 0"95).
Samples with values over 250 IU/1 on the Seralyzer are
repeated in dilution, and the correlation over the whole
range was equally good (r 0"93, slope 0"95).
The results from the Seralyzer on patient sample were on
average 6"7% higher than the Centrifichem values. The
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differences in the control sera were greater, but this
difference is probably due to a matrix effect affecting the
two methods differently.
Values for control sera and normal ranges should,
therefore, be determined for the Seralyzer AST method
before routine use of the system.
and which demonstrates performance essentially equiv-
alent to conventional high-cost, automated laboratory
methodology. The Seralyzer AST system would be
especially suitable for emergency or out-of-hours estima-
tions in this routine hospital laboratory, particularly
where this is accompanied by rapidCK measurements on
the same system.
In many analyses, bilirubin is said to be a possible
interfering substance, and for this reason total bilirubin
was measured at the same time as the AST levels.
Although the bilirubin values covered the range 0-280
mol/l, no direct effect of bilirubin on either method
could be demonstrated.
In summary, a rapid (4 min) AST method is now
available, which is simple to use by the trained operator,
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HPLC ’86: THE TENTH INTERNATIONAL SYMPOSIUM ON COLUMN LIQUID
CHROMATOGRAPHY
To be held at the Sheraton Palace Hotel, San Francisco, USA from 18 to 23 May 1986.
Chaired by Dr Ronald E. Majors of Varian Associates, HPLC ’86 has the following sponsors"
San Francisco Bay Area Chromatography Colloquium
Federation of Chromatography Discussion Groups
Chromatography Sub-Division of the American Society
Japanese Society of Analytical Chemistry and Agencies
American Society for Testing Materials E-19 on Chromatography
Arbeitskreis Chromatographic der Fachgruppe
Chemie der Gesellschaft Deutscher Chemiker
The Chromatographic Society (UK)
.G.roupement pour l’Advancement des M6thodes et Physico-Chimiques d’Analyse (G.A.M.S.)
Osterreichische Gesellschaft fiir Mikrochemie und Chemic
Analytical Chemistry Divisions of the Koninkliijke Chemische Vereniging
Schweizerischer Chemiker-Verband
Societe Chimique de France
Svenska Kemistsamfundet
The scientific program will include numerous oral and poster authors on an individual or small group basis in order to discuss
pa’pers on the latest HPLC applications, theory, columns, and the subtleties and ’how to’s’ of their contributions.
instrumentation. Special lecture sessions will be devoted to
specific topics such as the use of HPLC in biotechnology, Poster sessions will not be scheduled opposite lecture sessions to
techniques of optimization of methods development, new provide sufficient time for poster viewing and discussion.
detection possibilities, and micro LC columns.
Exhibition
Discussion sessions will serve to augment the formal presenta-
tions and allow the participants to take an active part in In conjunction with the Symposium, an exhibition of the
exploring solutions to their chromatography problems, the latest liquid chromatography instrumentation, columns,
future potential ofHPLC, and the exchange of ideas, and accessories is planned. Booth space is limited and
early response has been advised.
Poster papers will again be a mainstay of HPLC ’86. These
poster sessions are always popular because they give interested Further details from Shirley Schlessinger, Symposium Manager,
participants the opportunity to spend more time with the 400 E. Randolph Drive, Chicago, Illinois 60601, USA.
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